BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8560842)

  • 41. Lipid profile and atherogenic indices soon after birth in Japanese preterm infants.
    Shoji H; Murano Y; Mori M; Matsunaga N; Ohkawa N; Suganuma H; Ikeno M; Hisata K; Hirayama S; Ueno T; Miida T; Shimizu T
    Acta Paediatr; 2014 Jan; 103(1):22-6. PubMed ID: 24117869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
    Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
    Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of proteinuria in patients with acute ischemic brain disease].
    Jovicić A; Raicević R; Magdić B; Dincić E
    Vojnosanit Pregl; 1999; 56(2):129-34. PubMed ID: 10437417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histochemical changes in the level of insulin in the erythrocytes and of glucose in the blood in the most acute phase of ischemic stroke].
    Krychun II
    Lik Sprava; 1998 Jun; (4):74-6. PubMed ID: 9784709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New findings concerning pathogenesis of disorders of cerebral circulation].
    Gannushkina IV; Antelava AL; Baranchikova MV; Konorova IL; Kukleĭ ML; Dzhibladze DN; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):4-8. PubMed ID: 11517475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of the degree of cerebral atherosclerosis on the changes in hemostatic system in patients with ischemic brain disease and atherosclerotic encephalopathy.
    Raicević R; Jovicić A; Mandić-Radić S; Krgović M; Magdić B; Marković L; Hajduković D; Jovic P
    Vojnosanit Pregl; 1999; 56(5):461-70. PubMed ID: 10645149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Italian study of cerebral reversible ischemic attacks. II. The hematocrit and hemoglobin distribution and its relationship between clinical pattern and angiographic abnormalities.
    Nardini M; Rossi G; Martini A; Bono G; Brambilla G; Candelise L; De Zanche L; Iadecola C; Inzitari D; Mariani F; Fieschi C
    Eur Neurol; 1983; 22 Suppl 1():83-8. PubMed ID: 6884406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of HLA antigen frequency and lipid metabolic indices in patients with various locations of atherosclerosis].
    Kovalev IuR; Serova LD; Litmanovich KIu; Dzeranova NIa; Rudenko DI
    Gematol Transfuziol; 1988 Oct; 33(10):19-23. PubMed ID: 3215456
    [No Abstract]   [Full Text] [Related]  

  • 49. [The role of microwave resonance therapy in the combined treatment of patients with cerebral atherosclerosis].
    Kuz'menko VM
    Lik Sprava; 1998; (7):146-8. PubMed ID: 10050487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The pathogenetic mechanisms of an ischemic stroke].
    Grigorova IA
    Lik Sprava; 1998; (1):58-65. PubMed ID: 9621617
    [No Abstract]   [Full Text] [Related]  

  • 51. [Disorders of lipid levels and metabolism as risk factors for the onset and development of cerebral arteriosclerosis and cerebral ischemia].
    Jovicić A; Veljancić D; Dordević D; Malicević Z
    Vojnosanit Pregl; 1996; 53(2):125-32. PubMed ID: 9214092
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum lipids and cerebral atherosclerosis in terminal cancer patients.
    Berry JF; Resch JA; Baker AB
    Neurology; 1966 Jul; 16(7):673-9. PubMed ID: 5949434
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of transfer of human ApoA1 gene on development of dyslipoproteinemias in rats: Age peculiarities.
    Frolkis VV; Kordjum VA; Bogatskaya LN; Novikova SN; Shulzhenko VN; Kostetsky IE; Mozzhukhina TG; Potapenko RI; Sabko VE; Paramonova GI; Shkapenko AL
    Arch Gerontol Geriatr; 1991; 13(3):225-35. PubMed ID: 15374415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fibrinogen and lipids: associated risk factors for ischemic cerebral stroke].
    Honczarenko K; Torbus-Lisiecka B; Osuch Z; Nocoń D; Nowacki P; Potemkowski A; Narolewska A
    Neurol Neurochir Pol; 1999; 33(3):557-65. PubMed ID: 10540718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Serum apolipoproteins A1, B and Apo A1/Apo B index in children with advanced chronic renal failure and on dialysis].
    Puziewicz-Zmonarska A; Zwolińska D; Makulska I; Zmonarski SC
    Pol Merkur Lekarski; 2003 Apr; 14(82):299-303. PubMed ID: 12868188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensitivity of atherosclerosis indices in patients with ischemic brain disease].
    Marić D; Ivanisević V; Ilić T; Jović P
    Vojnosanit Pregl; 1994; 51(4):271-6. PubMed ID: 8560842
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.